We are live on
!
Find out more
Atossa Therapeutics
ATOS
ATOS
56 hedge funds and large institutions have $15.8M invested in Atossa Therapeutics in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 23 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
29% more call options, than puts
Call options by funds: $1.25M | Put options by funds: $971K
0.22% less ownership
Funds ownership: 1.23% → 1% (-0.22%)
23% less funds holding
Funds holding: 73 → 56 (-17)
37% less capital invested
Capital invested by funds: $25M → $15.8M (-$9.18M)
70% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 23
77% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 22
Holders
56
Holders Change
-17
Holders Change %
-23.29%
% of All Funds
0.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
7
Reduced
23
Closed
22
Calls
$1.25M
Puts
$971K
Net Calls
+$283K
Net Calls Change
+$420K
Top Buyers
| 1 |
Mariner
Overland Park,
Kansas
|
+$102K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$69.6K |
| 3 |
Two Sigma Investments
New York
|
+$57.3K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$24.5K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$21.4K |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$866K |
| 2 |
Millennium Management
New York
|
-$837K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$676K |
| 4 |
D.E. Shaw & Co
New York
|
-$496K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$211K |
